Kalpana Gupta, MD
Professor, Medicine
Biography
Dr. Gupta is Chief, Section of Infectious Diseases at the Veterans Administration Boston Healthcare System, and Professor of Medicine at Chobanian and Avedisian School of Medicine. Her primary research focus over the past decade has been on optimizing treatment regimens and prevention strategies for urinary tract infections (UTIs) in women. She is Chair of the IDSA UTI guideline update committee. She is currently PI of a multi-site NIH-funded randomized controlled trial of cranberry juice cocktail to prevent recurrent UTI in women and just completed a randomized trial of short course nitrofurantoin for treatment of acute cystitis in women. As a natural progression of her work on antimicrobial resistance in community-acquired UTIs, she is now embarking on a new research area, namely the evaluation of the prevalence and molecular epidemiology of MRSA infections in the veteran population.
Other Positions
- VA Boston Healthcare System
Websites
Education
- Stony Brook University, MD
- University of Washington School of Public Health, MPH
- Stony Brook University, BA
Publications
- Published on 7/3/2023
Suzuki H, Perencevich EN, Hockett Sherlock S, Clore GS, O'Shea AMJ, Forrest GN, Pfeiffer CD, Safdar N, Crnich C, Gupta K, Strymish J, Lira GB, Bradley S, Cadena-Zuluaga J, Rubin M, Bittner M, Morgan D, DeVries A, Miell K, Alexander B, Schweizer ML. Implementation of a Prevention Bundle to Decrease Rates of Staphylococcus aureus Surgical Site Infection at 11 Veterans Affairs Hospitals. JAMA Netw Open. 2023 Jul 03; 6(7):e2324516. PMID: 37471087.
Read at: PubMed - Published on 6/21/2023
Gillespie C, Sitter K, McConeghy KW, Strymish J, Gupta K, Hartmann CW, Borzecki AM. Facilitators and Barriers to Verifying Penicillin Allergies in a Veteran Nursing Home Population. J Allergy Clin Immunol Pract. 2023 Sep; 11(9):2848-2854.e3. PMID: 37352930.
Read at: PubMed - Published on 4/11/2023
Linsenmeyer K, Mohr D, Gupta K, Doshi S, Gifford AL, Charness ME. Sickness presenteeism in healthcare workers during the coronavirus disease 2019 (COVID-19) pandemic: An observational cohort study. Infect Control Hosp Epidemiol. 2023 Apr 11; 1-4. PMID: 37039605.
Read at: PubMed - Published on 3/1/2023
O'Brien WJ, Gupta K, Itani KMF. Estimated Risk of Adverse Surgical Outcomes Among Patients With Recent COVID-19 Infection Using Target Trial Emulation Methods. JAMA Netw Open. 2023 Mar 01; 6(3):e234876. PMID: 36976565.
Read at: PubMed - Published on 3/1/2023
O'Brien WJ, Gupta K, Itani KMF. Estimated Risk of Adverse Surgical Outcomes Among Patients With Recent COVID-19 Infection Using Target Trial Emulation Methods. JAMA Netw Open. 2023 Mar 01; 6(3):e234876. PMID: 36976565.
Read at: PubMed - Published on 9/7/2022
Charness ME, Gupta K, Stack G, Strymish J, Adams E, Lindy DC, Mohri H, Ho DD. Rebound of SARS-CoV-2 Infection after Nirmatrelvir-Ritonavir Treatment. N Engl J Med. 2022 Sep 15; 387(11):1045-1047. PMID: 36069968.
Read at: PubMed - Published on 8/31/2022
Claeys KC, Trautner BW, Leekha S, Coffey KC, Crnich CJ, Diekema DJ, Fakih MG, Goetz MB, Gupta K, Jones MM, Leykum L, Liang SY, Pineles L, Pleiss A, Spivak ES, Suda KJ, Taylor JM, Rhee C, Morgan DJ. Optimal Urine Culture Diagnostic Stewardship Practice-Results from an Expert Modified-Delphi Procedure. Clin Infect Dis. 2022 Aug 31; 75(3):382-389. PMID: 34849637.
Read at: PubMed - Published on 6/17/2022
Dhanani M, Krishnamoorthy A, Ciolino JD, Gupta K, Strymish JM. Prophylaxis against spontaneous bacterial peritonitis: Too much or too little? Antimicrob Steward Healthc Epidemiol. 2022; 2(1):e95. PMID: 36483431.
Read at: PubMed - Published on 6/1/2022
Stern RA, Charness ME, Gupta K, Koutrakis P, Linsenmeyer K, Madjarov R, Martins MAG, Lemos B, Dowd SE, Garshick E. Concordance of SARS-CoV-2 RNA in Aerosols From a Nurses Station and in Nurses and Patients During a Hospital Ward Outbreak. JAMA Netw Open. 2022 Jun 01; 5(6):e2216176. PMID: 35675074.
Read at: PubMed - Published on 4/7/2022
Johnson S, Gerding DN, Li X, Reda DJ, Donskey CJ, Gupta K, Goetz MB, Climo MW, Gordin FM, Ringer R, Johnson N, Johnson M, Calais LA, Goldberg AM, Ge L, Haegerich T. Defining optimal treatment for recurrent Clostridioides difficile infection (OpTION study): A randomized, double-blind comparison of three antibiotic regimens for patients with a first or second recurrence. Contemp Clin Trials. 2022 May; 116:106756. PMID: 35398532.
Read at: PubMed
View 133 more publications: View full profile at BUMC